|
1
|
Maira SM, Galetic I, Brazil DP, Kaech S,
Ingley E, Thelen M and Hemmings BA: Carboxyl-terminal modulator
protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the
plasma membrane. Science. 294:374–380. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Manning BD and Toker A: AKT/PKB signaling:
Navigating the network. Cell. 169:381–405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Glaviano A, Foo ASC, Lam HY, Yap KCH,
Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B, et al:
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies
in cancer. Mol Cancer. 22:1382023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Z: Regulation of cell cycle
progression by growth factor-induced cell signaling. Cells.
10:33272021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parcellier A, Tintignac LA, Zhuravleva E,
Cron P, Schenk S, Bozulic L and Hemmings BA: Carboxy-terminal
modulator protein (CTMP) is a mitochondrial protein that sensitizes
cells to apoptosis. Cell Signal. 21:639–650. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Piao L, Li Y, Yang KJ, Park KA, Byun HS,
Won M, Hong J, Kim JL, Kweon GR, Hur GM, et al: Heat shock protein
70-mediated sensitization of cells to apoptosis by
carboxyl-terminal modulator protein. BMC Cell Biol. 10:532009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jin H, Xu CX, Lim HT, Park SJ, Shin JY,
Chung YS, Park SC, Chang SH, Youn HJ, Lee KH, et al: High dietary
inorganic phosphate increases lung tumorigenesis and alters Akt
signaling. Am J Respir Crit Care Med. 179:59–68. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hwang SK, Kwon JT, Park SJ, Chang SH, Lee
ES, Chung YS, Beck GR Jr, Lee KH, Piao L, Park J and Cho MH:
Lentivirus-mediated carboxyl-terminal modulator protein gene
transfection via aerosol in lungs of K-ras null mice. Gene Ther.
14:1721–1730. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Niu F, Duan Y, Man Y, Liu W, Dai T, Zhang
H, Li C and Wei D: Mitochondrial protein LETM1 and its-mediated
CTMP are potential therapeutic targets for endometrial cancer.
Anticancer Drugs. 33:632–641. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simon PO Jr, McDunn JE, Kashiwagi H, Chang
K, Goedegebuure PS, Hotchkiss RS and Hawkins WG: Targeting AKT with
the proapoptotic peptide, TAT-CTMP: A novel strategy for the
treatment of human pancreatic adenocarcinoma. Int J Cancer.
125:942–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Knobbe CB, Reifenberger J, Blaschke B and
Reifenberger G: Hypermethylation and transcriptional downregulation
of the carboxyl-terminal modulator protein gene in glioblastomas. J
Natl Cancer Inst. 96:483–486. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang JW, Jung SN, Kim JH, Shim GA, Park
HS, Liu L, Kim JM, Park J and Koo BS: Carboxyl-terminal modulator
protein positively acts as an oncogenic driver in head and neck
squamous cell carcinoma via regulating Akt phosphorylation. Sci
Rep. 6:285032016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu YP, Liao WC, Ger LP, Chen JC, Hsu TI,
Lee YC, Chang HT, Chen YC, Jan YH, Lee KH, et al: Carboxyl-terminal
modulator protein positively regulates Akt phosphorylation and acts
as an oncogenic driver in breast cancer. Cancer Res. 73:6194–6205.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin CH, Lin WD, Huang YC, Chen YC, Loh ZJ,
Ger LP, Lin FC, Li HY, Cheng HC, Lee KH, et al: Carboxyl-terminal
modulator protein facilitates tumor metastasis in triple-negative
breast cancer. Cancer Gene Ther. 30:404–413. 2023.PubMed/NCBI
|
|
15
|
Bolze PA, Lopez J, Allias F, Hajri T,
Patrier S, Devouassoux-Shisheboran M, Massardier J, You B, Golfier
F and Mallet F: Transcriptomic and immunohistochemical approaches
identify HLA-G as a predictive biomarker of gestational
choriocarcinoma resistance to monochemotherapy. Gynecol Oncol.
158:785–793. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ni FB, Lin Z, Fan XH, Shi KQ, Ao JY, Wang
XD and Chen RC: A novel genomic-clinicopathologic nomogram to
improve prognosis prediction of hepatocellular carcinoma. Clin Chim
Acta. 504:88–97. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang S, Li D, Zhao M, Yang F, Sang C, Yan
C, Wang Z and Li Y: Exosomal miR-183-5p shuttled by M2 polarized
tumor-associated macrophage promotes the development of colon
cancer via targeting THEM4 mediated PI3K/AKT and NF-κB pathways.
Front Oncol. 11:6726842021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen YC, Li HY, Liang JL, Ger LP, Chang
HT, Hsiao M, Calkins MJ, Cheng HC, Chuang JH and Lu PJ: CTMP, a
predictive biomarker for trastuzumab resistance in HER2-enriched
breast cancer patient. Oncotarget. 8:29699–29710. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Block M, Grundker C, Fister S, Kubin J,
Wilkens L, Mueller MD, Hemmerlein B, Emons G and Günthert AR:
Inhibition of the AKT/mTOR and erbB pathways by gefitinib,
perifosine and analogs of gonadotropin-releasing hormone I and II
to overcome tamoxifen resistance in breast cancer cells. Int J
Oncol. 41:1845–1854. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li J, Shan W and Zuo Z: Age-related
upregulation of carboxyl terminal modulator protein contributes to
the decreased brain ischemic tolerance in older rats. Mol
Neurobiol. 55:6145–6154. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Y, Nie H, Tian L, Tong L, Deng J,
Zhang Y, Dong H and Xiong L: Sevoflurane preconditioning-induced
neuroprotection is associated with Akt activation via
carboxy-terminal modulator protein inhibition. Br J Anaesth.
114:327–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kao MH, Huang CY, Cheung WM, Yan YT, Chen
JJ, Ho YS, Hsu CY and Lin TN: Activating transcription factor 3
diminishes ischemic cerebral infarct and behavioral deficit by
downregulating carboxyl-terminal modulator protein. Int J Mol Sci.
24:23062023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang CY, Chen JJ, Wu JS, Tsai HD, Lin H,
Yan YT, Hsu CY, Ho YS and Lin TN: Novel link of anti-apoptotic ATF3
with pro-apoptotic CTMP in the ischemic brain. Mol Neurobiol.
51:543–557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao S, Fu J, Liu F, Rastogi R, Zhang J
and Zhao Y: Small interfering RNA directed against CTMP reduces
acute traumatic brain injury in a mouse model by activating Akt.
Neurol Res. 36:483–490. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Y, Cai M, Deng J, Tian L, Wang S,
Tong L, Dong H and Xiong L: Elevated expression of carboxy-terminal
modulator protein (CTMP) aggravates brain ischemic injury in
diabetic db/db Mice. Neurochem Res. 41:2179–2189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miyawaki T, Ofengeim D, Noh KM,
Latuszek-Barrantes A, Hemmings BA, Follenzi A and Zukin RS: The
endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced
neuronal death. Nat Neurosci. 12:618–626. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park J, Li Y, Kim SH, Yang KJ, Kong G,
Shrestha R, Tran Q, Park KA, Jeon J, Hur GM, et al: New players in
high fat diet-induced obesity: LETM1 and CTMP. Metabolism.
63:318–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mondal AK, Sharma NK, Elbein SC and Das
SK: Allelic expression imbalance screening of genes in chromosome
1q21-24 region to identify functional variants for Type 2 diabetes
susceptibility. Physiol Genomics. 45:509–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen N, Hao J, Li L, Li F, Liu S and Duan
H: Carboxy-terminal modulator protein attenuated extracellular
matrix deposit by inhibiting phospho-Akt, TGF-β1 and α-SMA in
kidneys of diabetic mice. Biochem Biophys Res Commun. 474:753–760.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu X, Yang Q, Zhu LH, Liu J, Deng KQ, Zhu
XY, Liu Y, Gong J, Zhang P, Li S, et al: Carboxyl-terminal
modulator protein ameliorates pathological cardiac hypertrophy by
suppressing the protein kinase B signaling pathway. J Am Heart
Assoc. 7:e0086542018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhuravleva E, Gut H, Hynx D, Marcellin D,
Bleck CK, Genoud C, Cron P, Keusch JJ, Dummler B, Esposti MD and
Hemmings BA: Acyl coenzyme A thioesterase Them5/Acot15 is involved
in cardiolipin remodeling and fatty liver development. Mol Cell
Biol. 32:2685–2697. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Swarbrick CMD, Nanson JD, Patterson EI and
Forwood JKL: Structure, function, and regulation of thioesterases.
Prog Lipid Res. 79:1010362020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tillander V, Alexson SEH and Cohen DE:
Deactivating fatty acids: Acyl-CoA thioesterase-mediated control of
lipid metabolism. Trends Endocrinol Metab. 28:473–484. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Brocker C, Carpenter C, Nebert DW and
Vasiliou V: Evolutionary divergence and functions of the human
acyl-CoA thioesterase gene (ACOT) family. Hum Genomics. 4:411–420.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao H, Martin BM, Bisoffi M and
Dunaway-Mariano D: The Akt C-terminal modulator protein is an
acyl-CoA thioesterase of the Hotdog-Fold family. Biochemistry.
48:5507–5509. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao H, Lim K, Choudry A, Latham JA,
Pathak MC, Dominguez D, Luo L, Herzberg O and Dunaway-Mariano D:
Correlation of structure and function in the human hotdog-fold
enzyme hTHEM4. Biochemistry. 51:6490–6492. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jones PF, Jakubowicz T and Hemmings BA:
Molecular cloning of a second form of rac protein kinase. Cell
Regul. 2:1001–1009. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng JQ, Godwin AK, Bellacosa A, Taguchi
T, Franke TF, Hamilton TC, Tsichlis PN and Testa JR: AKT2, a
putative oncogene encoding a member of a subfamily of
protein-serine/threonine kinases, is amplified in human ovarian
carcinomas. Proc Natl Acad Sci USA. 89:9267–9271. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Brodbeck D, Cron P and Hemmings BA: A
human protein kinase Bgamma with regulatory phosphorylation sites
in the activation loop and in the C-terminal hydrophobic domain. J
Biol Chem. 274:9133–9136. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Song G, Ouyang G and Bao S: The activation
of Akt/PKB signaling pathway and cell survival. J Cell Mol Med.
9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nicholson KM and Anderson NG: The protein
kinase B/Akt signalling pathway in human malignancy. Cell Signal.
14:381–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ruan GX and Kazlauskas A: Focus on
molecules: Akt (PKB). Exp Eye Res. 93:570–571. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Andjelkovic M, Alessi DR, Meier R,
Fernandez A, Lamb NJ, Frech M, Cron P, Cohen P, Lucocq JM and
Hemmings BA: Role of translocation in the activation and function
of protein kinase B. J Biol Chem. 272:31515–31524. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Stephens L, Anderson K, Stokoe D,
Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB,
McCormick F, Tempst P, et al: Protein kinase B kinases that mediate
phosphatidylinositol 3,4,5-trisphosphate-dependent activation of
protein kinase B. Science. 279:710–714. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Alessi DR, Andjelkovic M, Caudwell B, Cron
P, Morrice N, Cohen P, Morrice N, Cohen P and Hemmings BA:
Mechanism of activation of protein kinase B by insulin and IGF-1.
EMBO J. 15:6541–6551. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sarbassov DD, Guertin DA, Ali SM and
Sabatini DM: Phosphorylation and regulation of Akt/PKB by the
rictor-mTOR complex. Science. 307:1098–1101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhuravleva E: Structural and functional
characterization of novel mitochondrial acyl-CoA thioesterase
Them5/CTMP2 (Doctoral Thesis). University of Basel; 2013
|
|
48
|
Brazil DP, Park J and Hemmings BA: PKB
binding proteins. Getting in on the Akt. Cell. 111:293–303. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ono H, Sakoda H, Fujishiro M, Anai M,
Kushiyama A, Fukushima Y, Katagiri H, Ogihara T, Oka Y, Kamata H,
et al: Carboxy-terminal modulator protein induces Akt
phosphorylation and activation, thereby enhancing antiapoptotic,
glycogen synthetic, and glucose uptake pathways. Am J Physiol Cell
Physiol. 293:C1576–C1585. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhou Q, Leeman SE and Amar S: Signaling
mechanisms involved in altered function of macrophages from
diet-induced obese mice affect immune responses. Proc Natl Acad Sci
USA. 106:10740–1075. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shin JY, Chung YS, Kang B, Jiang HL, Yu
DY, Han K, Chae C, Moon JH, Jang G and Cho MH: Co-delivery of LETM1
and CTMP synergistically inhibits tumor growth in H-ras12V liver
cancer model mice. Cancer Gene Ther. 20:186–194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yu H, Deng J and Zuo Z: High-fat diet
reduces neuroprotection of isoflurane post-treatment: Role of
carboxyl-terminal modulator protein-Akt signaling. Obesity (Silver
Spring). 22:2396–2405. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhao Y, Zhang Y, Khas E, Bai C, Cao Q and
Ao C: Transcriptome analysis reveals candidate genes of the
synthesis of branched-chain fatty acids related to mutton flavor in
the lamb liver using Allium mongolicum Regel extract. J Anim Sci.
100:skac2562022. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yu B, Zheng Y, Alexander D, Morrison AC,
Coresh J and Boerwinkle E: Genetic determinants influencing human
serum metabolome among African Americans. PLoS Genet.
10:e10042122014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hwang SK, Minai-Tehrani A, Yu KN, Chang
SH, Kim JE, Lee KH, Park J, Beck GR Jr and Cho MH:
Carboxyl-terminal modulator protein induces apoptosis by regulating
mitochondrial function in lung cancer cells. Int J Oncol.
40:1515–1524. 2012.PubMed/NCBI
|
|
56
|
Piao L, Li Y, Kim SJ, Sohn KC, Yang KJ,
Park KA, Byun HS, Won M, Hong J, Hur GM, et al: Regulation of
OPA1-mediated mitochondrial fusion by leucine
zipper/EF-hand-containing transmembrane protein-1 plays a role in
apoptosis. Cell Signal. 21:767–777. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Parcellier A, Tintignac LA, Zhuravleva E,
Dummler B, Brazil DP, Hynx D, Cron P, Schenk S, Olivieri V and
Hemmings BA: The carboxy-terminal modulator protein (CTMP)
regulates mitochondrial dynamics. PLoS One. 4:e54712009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Vo TT, Kong G, Kim C, Juang U, Gwon S,
Jung W, Nguyen H, Kim SH and Park J: Exploring scavenger receptor
class F member 2 and the importance of scavenger receptor family in
prediagnostic diseases. Toxicol Res. 39:341–353. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang B, Xu X, Liu X, Wang D, Zhuang H, He
X, Han T and Hong J: Enolase-phosphatase 1 acts as an oncogenic
driver in glioma. J Cell Physiol. 236:1184–1194. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Tews B, Roerig P, Hartmann C, Hahn M,
Felsberg J, Blaschke B, Sabel M, Kunitz A, Toedt G, Neben K, et al:
Hypermethylation and transcriptional downregulation of the CITED4
gene at 1p34.2 in oligodendroglial tumours with allelic losses on
1p and 19q. Oncogene. 26:5010–5016. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Knobbe CB, Trampe-Kieslich A and
Reifenberger G: Genetic alteration and expression of the
phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human
glioblastomas. Neuropathol Appl Neurobiol. 31:486–490. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gao S, Gang J, Yu M, Xin G and Tan H:
Computational analysis for identification of early diagnostic
biomarkers and prognostic biomarkers of liver cancer based on GEO
and TCGA databases and studies on pathways and biological functions
affecting the survival time of liver cancer. BMC Cancer.
21:7912021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yamasaki D, Kawabe N, Nakamura H,
Tachibana K, Ishimoto K, Tanaka T, Aburatani H, Sakai J, Hamakubo
T, Kodama T and Doi T: Fenofibrate suppresses growth of the human
hepatocellular carcinoma cell via PPARalpha-independent mechanisms.
Eur J Cell Biol. 90:657–664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Niu Q, Zhao W, Wang J, Li C, Yan T, Lv W,
Wang G, Duan W, Zhang T, Wang K and Zhou D: LicA induces autophagy
through ULK1/Atg13 and ROS pathway in human hepatocellular
carcinoma cells. Int J Mol Med. 41:2601–2608. 2018.PubMed/NCBI
|
|
65
|
Garrido-Castro AC, Lin NU and Polyak K:
Insights into molecular classifications of triple-negative breast
cancer: Improving patient selection for treatment. Cancer Discov.
9:176–198. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Gutierrez-Barrera AM, Menter DG,
Abbruzzese JL and Reddy SA: Establishment of three-dimensional
cultures of human pancreatic duct epithelial cells. Biochem Biophys
Res Commun. 358:698–703. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hwang SK, Lim HT, Minai-Tehrani A, Lee ES,
Park J, Park SB, Beck GR Jr and Cho MH: Repeated aerosol delivery
of carboxyl-terminal modulator protein suppresses tumor in the
lungs of K-rasLA1 mice. Am J Respir Crit Care Med. 179:1131–1140.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang B, Cai Y, Li X, Kong Y, Fu H and Zhou
J: ETV4 mediated lncRNA C2CD4D-AS1 overexpression contributes to
the malignant phenotype of lung adenocarcinoma cells via
miR-3681-3p/NEK2 axis. Cell Cycle. 20:2607–2618. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Gao S, Tan H and Li D: Oridonin suppresses
gastric cancer SGC-7901 cell proliferation by targeting the
TNF-alpha/androgen receptor/TGF-beta signalling pathway axis. J
Cell Mol Med. 27:2661–2674. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Strykowski R and Adegunsoye A: Idiopathic
pulmonary fibrosis and progressive pulmonary fibrosis. Immunol
Allergy Clin North Am. 43:209–228. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gul A, Yang F, Xie C, Du W, Mohammadtursun
N, Wang B, Le J and Dong J: Pulmonary fibrosis model of mice
induced by different administration methods of bleomycin. BMC Pulm
Med. 23:912023. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Shin N, Yi MH, Kim S, Baek H, Triantafillu
UL, Park J and Kim DW: Astrocytic expression of CTMP following an
excitotoxic lesion in the mouse hippocampus. Exp Neurobiol.
26:25–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Chae KS, Martin-Caraballo M, Anderson M
and Dryer SE: Akt activation is necessary for growth factor-induced
trafficking of functional K(Ca) channels in developing
parasympathetic neurons. J Neurophysiol. 93:1174–1182. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Lampropoulos IC, Malli F, Sinani O,
Gourgoulianis KI and Xiromerisiou G: Worldwide trends in mortality
related to Parkinson's disease in the period of 1994–2019: Analysis
of vital registration data from the WHO mortality database. Front
Neurol. 13:9564402022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Dick F, Nido GS, Alves GW, Tysnes OB,
Nilsen GH, Dolle C and Tzoulis C: Differential transcript usage in
the Parkinson's disease brain. PLoS Genet. 16:e10091822020.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Dolan ME, El Charif O, Wheeler HE, Gamazon
ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton RJ,
Vaughn DJ, Beard CJ, et al: Clinical and genome-wide analysis of
cisplatin-induced peripheral neuropathy in survivors of adult-onset
cancer. Clin Cancer Res. 23:5757–5768. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ren B, Wan S, Wu H, Qu M, Chen Y, Liu L,
Jin M, Zhou Z and Shen H: Effect of different iodine levels on the
DNA methylation of PRKAA2, ITGA6, THEM4 and PRL genes in PI3K-AKT
signaling pathway and population-based validation from autoimmune
thyroiditis patients. Eur J Nutr. 61:3571–3583. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wang Q, He Y, Shen Y, Zhang Q, Chen D, Zuo
C, Qin J, Wang H, Wang J and Yu Y: Vitamin D inhibits COX-2
expression and inflammatory response by targeting thioesterase
superfamily member 4. J Biol Chem. 289:11681–1194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Nambou K, Nie X, Tong Y and Anakpa M:
Weighted gene co-expression network analysis and drug-gene
interaction bioinformatics uncover key genes associated with
various presentations of malaria infection in African children and
major drug candidates. Infect Genet Evol. 89:1047232021. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Wang J, Tierney L, Wilson C, Phillips V,
Goldman L, Mumaw C, Muang E and Walker CL: Carboxyl-terminal
modulator protein (CTMP) deficiency mitigates denervation-induced
skeletal muscle atrophy. Biochem Biophys Res Commun. 644:155–161.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhu M, Zheng R, Guo Y, Zhang Y and Zuo B:
NDRG4 promotes myogenesis via Akt/CREB activation. Oncotarget.
8:101720–10134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Wang J, Fry CME and Walker CL:
Carboxyl-terminal modulator protein regulates Akt signaling during
skeletal muscle atrophy in vitro and a mouse model of amyotrophic
lateral sclerosis. Sci Rep. 9:39202019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Sun X, Kellner M, Desai AA, Wang T, Lu Q,
Kangath A, Qu N, Klinger C, Fratz S, Yuan JX, et al: Asymmetric
dimethylarginine stimulates Akt1 phosphorylation via heat shock
protein 70-facilitated carboxyl-terminal modulator protein
degradation in pulmonary arterial endothelial cells. Am J Respir
Cell Mol Biol. 55:275–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Lu Z, Tang F, Li Z, Xie Z, Zheng H, Zhang
J, Gao Y, Lu Z, Cai Y, Lai Y and He Z: Characteristic genes and
immune infiltration analysis for acute rejection after kidney
transplantation. Dis Markers. 2022:65750522022. View Article : Google Scholar : PubMed/NCBI
|
